Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Thoracic Surgery

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 177 articles:
HTML format



Single Articles


    May 2020
  1. HUBER K, Ulmer H, Lang IM, Muhlberger V, et al
    Coronary interventions in Austria, Germany, and Switzerland.
    Eur Heart J. 2020 May 8. pii: 5834923. doi: 10.1093.
    PubMed    


    April 2020
  2. SATO T, Konishi T, Wakasa S, Oyama-Manabe N, et al
    Phosphoglyceride crystal deposition disease as a rare tumour after cardiac surgery.
    Eur Heart J. 2020 Apr 26. pii: 5825471. doi: 10.1093.
    PubMed    


    March 2020
  3. AHMAD Y, Howard JP, Arnold AD, Cook CM, et al
    Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2020 Mar 2. pii: 5771278. doi: 10.1093.
    PubMed     Abstract available


  4. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
    The muddy waters of the J-curve and coronary revascularization.
    Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
    PubMed    


    February 2020
  5. AGASTHI P, Tseng A, Mulpuru SK
    Appropriate cohort selection and its impact on a meta-analysis evaluating the efficacy of direct oral anticoagulants post-percutaneous coronary intervention.
    Eur Heart J. 2020 Feb 14. pii: 5736264. doi: 10.1093.
    PubMed    


    January 2020
  6. RUBATTU S, Volpe M
    BNP level and post-transcatheter aortic valve replacement outcome: an intriguing J-shaped relationship.
    Eur Heart J. 2020 Jan 6. pii: 5697062. doi: 10.1093.
    PubMed    


  7. TESTA L, Latib A, Brambilla N, De Marco F, et al
    Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
    Eur Heart J. 2020 Jan 6. pii: 5697056. doi: 10.1093.
    PubMed     Abstract available


  8. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
    The year in cardiology: coronary interventions.
    Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
    PubMed    


  9. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  10. CHEN S, Redfors B, O'Neill BP, Clavel MA, et al
    Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
    Eur Heart J. 2019 Dec 28. pii: 5688929. doi: 10.1093.
    PubMed     Abstract available


  11. STOREY RF, Valgimigli M, Cuisset T, Capodanno D, et al
    Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelines.
    Eur Heart J. 2019 Dec 23. pii: 5686014. doi: 10.1093.
    PubMed    


  12. KOGAME N, Serruys PW, Onuma Y
    Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.
    Eur Heart J. 2019 Dec 23. pii: 5686015. doi: 10.1093.
    PubMed    


  13. WELSH RC
    Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
    Eur Heart J. 2019 Dec 23. pii: 5686009. doi: 10.1093.
    PubMed    


  14. SIA CH, Gochuico CFS, Ong CC, Teo LL, et al
    A man with end-stage renal failure and uncontrolled hyperparathyroidism with repeat transcatheter aortic valve replacement in a surgical bioprosthetic aortic valve while avoiding patient-prosthesis mismatch.
    Eur Heart J. 2019 Dec 22. pii: 5684840. doi: 10.1093.
    PubMed    


  15. FURTADO RHM, Nicolau JC, Magnani G, Im K, et al
    Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2019 Dec 7. pii: 5663567. doi: 10.1093.
    PubMed     Abstract available


  16. LOPEZ-JIMENEZ F, Gersh BJ
    Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
    Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
    PubMed    


    November 2019
  17. LOPES RD, Hong H, Alexander JH
    Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
    Eur Heart J. 2019 Nov 27. pii: 5644218. doi: 10.1093.
    PubMed    


  18. CHEN S, Redfors B, Nazif T, Kirtane A, et al
    Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
    Eur Heart J. 2019 Nov 11. pii: 5621355. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  19. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


  20. BJORKLUND E, Nielsen SJ, Hansson EC, Karlsson M, et al
    Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
    Eur Heart J. 2019 Oct 22. pii: 5602556. doi: 10.1093.
    PubMed     Abstract available


  21. SYBURRA MT, Guettler N, D'Arcy JL, Nicol ED, et al
    Clinical occupational assessment pre- and post-cardiac surgery.
    Eur Heart J. 2019;40:3283-3286.
    PubMed    


    September 2019
  22. ABDEL-WAHAB M, Kitamura M, Holzhey D, Thiele H, et al
    Transcatheter aortic valve implantation with a new generation mechanically expanding valve in a patient with a protruding coronary stent into the sinus of Valsalva: the 'reversed-chimney' technique.
    Eur Heart J. 2019 Sep 24. pii: 5573049. doi: 10.1093.
    PubMed    


  23. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
    16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  24. LUSCHER TF
    Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.
    Eur Heart J. 2019;40:2549-2552.
    PubMed    


  25. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


  26. CALISKAN E, Falk V, Emmert MY
    Multiarterial grafting in coronary artery bypass grafting.
    Eur Heart J. 2019;40:2479-2481.
    PubMed    


  27. LE PAGE PT, Bellenger NG
    Completeness of revascularization: should we not consider assessment before and after coronary artery bypass grafting?
    Eur Heart J. 2019 Aug 7. pii: 5544747. doi: 10.1093.
    PubMed    


    July 2019
  28. NAZIF TM, Chen S, George I, Dizon JM, et al
    New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
    Eur Heart J. 2019;40:2218-2227.
    PubMed     Abstract available


    June 2019
  29. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  30. POZZOLI A, Gavazzoni M, Maisano F, Taramasso M, et al
    Transcatheter mitral valve replacement after transcatheter direct annuloplasty with Cardioband.
    Eur Heart J. 2019 Jun 5. pii: 5511702. doi: 10.1093.
    PubMed    


    May 2019
  31. SCHUNKERT H, Boening A, von Scheidt M, Lanig C, et al
    Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
    Eur Heart J. 2019 May 30. pii: 5506732. doi: 10.1093.
    PubMed     Abstract available


  32. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
    Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
    Eur Heart J. 2019 May 22. pii: 5492739. doi: 10.1093.
    PubMed     Abstract available


  33. DEVEREAUX PJ, Szczeklik W
    Myocardial injury after non-cardiac surgery: diagnosis and management.
    Eur Heart J. 2019 May 16. pii: 5490290. doi: 10.1093.
    PubMed     Abstract available


  34. MYERS PO, Nguyen-Tang T, Alibegovic-Zaza J, Inan I, et al
    Spontaneous haemorrhage on apixaban masquerading as obstructive cholangitis after heart surgery.
    Eur Heart J. 2019 May 9. pii: 5487606. doi: 10.1093.
    PubMed    


    April 2019
  35. SIONTIS GCM, Overtchouk P, Cahill TJ, Modine T, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.
    Eur Heart J. 2019 Apr 23. pii: 5477387. doi: 10.1093.
    PubMed     Abstract available


  36. JONES DA, Rathod KS, Koganti S, Lim P, et al
    The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention: an observational study from the Pan-London PCI (BCIS) Registry using an
    Eur Heart J. 2019 Apr 10. pii: 5443278. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  37. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
    Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
    PubMed     Abstract available


  38. GRABHER F, Hamm W, Massberg S, Orban M, et al
    Uncommon cause of progressive dyspnoea 12 years after coronary artery bypass surgery.
    Eur Heart J. 2019 Mar 12. pii: 5377349. doi: 10.1093.
    PubMed    


    February 2019
  39. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
    PubMed     Abstract available


  40. TURGEON RD, Althouse AD
    Inappropriate inclusion of multiple studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome.
    Eur Heart J. 2019 Feb 20. pii: 5345134. doi: 10.1093.
    PubMed    


  41. LUSCHER TF, Davies A
    Inclusion of multiple inappropriate studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome: editor's response.
    Eur Heart J. 2019 Feb 20. pii: 5345135. doi: 10.1093.
    PubMed    


  42. ZHU SJ, Thondapu V, Poon EKW, Serruys PW, et al
    Computational particle tracking to model platelet behaviour near malapposed coronary stent struts.
    Eur Heart J. 2019 Feb 15. pii: 5321137. doi: 10.1093.
    PubMed    



  43. Corrigendum to: Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patie
    Eur Heart J. 2019 Feb 7. pii: 5309035. doi: 10.1093.
    PubMed    


    January 2019
  44. BARTEL T, Muller S
    Concomitant mitral stenosis may be associated with low flow: what it means and how it potentially impacts on transcatheter aortic valve replacement.
    Eur Heart J. 2019 Jan 30. pii: 5304402. doi: 10.1093.
    PubMed    


  45. WELZ A, Heinemann MK, Diegeler A
    Outcome after transvascular transcatheter aortic valve implantation in 2016: a closer look.
    Eur Heart J. 2019 Jan 25. pii: 5301476. doi: 10.1093.
    PubMed    


  46. SEIFFERT M, Walther T, Hamm C, Falk V, et al
    The DEDICATE Trial: An independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients.
    Eur Heart J. 2019;40:331-333.
    PubMed    


  47. CREA F, Bairey Merz CN, Beltrame JF, Berry C, et al
    Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
    Eur Heart J. 2019 Jan 4. pii: 5273474. doi: 10.1093.
    PubMed     Abstract available


  48. YE Z, Lu H, Su Q, Long M, et al
    Short-term and long-term effects of a loading dose of atorvastatin before percutaneous coronary intervention on major adverse cardiovascular events in patients with acute coronary syndrome: a meta-analysis of 13 randomized controlled trials.
    Eur Heart J. 2019 Jan 3. pii: 5272474. doi: 10.1093.
    PubMed     Abstract available


  49. YOSHIKAWA Y, Kimura T
    Percutaneous coronary intervention in stable coronary artery disease: still in equipoise?
    Eur Heart J. 2019 Jan 2. pii: 5272354. doi: 10.1093.
    PubMed    


  50. DUDEK D, Dziewierz A, Stone G, Wijns W, et al
    The year in cardiology 2018: coronary interventions.
    Eur Heart J. 2019 Jan 2. pii: 5265297. doi: 10.1093.
    PubMed    


    December 2018
  51. ZIMMERMANN FM, Omerovic E, Fournier S, Kelbaek H, et al
    Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
    Eur Heart J. 2018 Dec 28. pii: 5265290. doi: 10.1093.
    PubMed     Abstract available


  52. ASAMI M, Windecker S, Praz F, Lanz J, et al
    Transcatheter aortic valve replacement in patients with concomitant mitral stenosis.
    Eur Heart J. 2018 Dec 28. pii: 5265291. doi: 10.1093.
    PubMed     Abstract available


  53. SEEGER J, Kapadia SR, Kodali S, Linke A, et al
    Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Eur Heart J. 2018 Dec 24. pii: 5259357. doi: 10.1093.
    PubMed     Abstract available


  54. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Abstract available


  55. SONDERGAARD L
    Transcatheter aortic valve implantation in patients with longer life expectancy: what measures are needed?
    Eur Heart J. 2018 Dec 1. pii: 5224503. doi: 10.1093.
    PubMed    


    November 2018
  56. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
    Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
    Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
    PubMed     Abstract available


  57. URENA M, Himbert D
    Response: Acute haemolysis after transcatheter mitral valve implantation.
    Eur Heart J. 2018 Nov 29. pii: 5219611. doi: 10.1093.
    PubMed    


  58. JONVEAUX M, Gallet R, Mouillet G, Lim P, et al
    Acute haemolysis after transcatheter mitral valve implantation.
    Eur Heart J. 2018 Nov 29. pii: 5219667. doi: 10.1093.
    PubMed    


  59. CANDREVA A, Matter CM
    Is the amount of glow predicting the fire? Residual inflammatory risk after percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 19. pii: 5173735. doi: 10.1093.
    PubMed    


  60. GOLWALA H, Cannon CP, Bhatt DL
    Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 5. pii: 5161202. doi: 10.1093.
    PubMed    


  61. GRAGNANO F, Calabro P, Valgimigli M
    Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?
    Eur Heart J. 2018 Nov 5. pii: 5161206. doi: 10.1093.
    PubMed    


    October 2018
  62. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Abstract available


  63. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
    Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
    PubMed     Abstract available


  64. YOON SH, Whisenant BK, Bleiziffer S, Delgado V, et al
    Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.
    Eur Heart J. 2018 Oct 23. pii: 5143983. doi: 10.1093.
    PubMed     Abstract available


  65. CARREL T, Eberle B, Pasic M
    Cardioband to treat functional mitral regurgitation: a word of caution.
    Eur Heart J. 2018 Oct 22. pii: 5142408. doi: 10.1093.
    PubMed    


    September 2018
  66. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Abstract available


  67. SHAPIRA Y
    The Cardioband annuloplasty system: is it ready for prime time?
    Eur Heart J. 2018 Sep 12. pii: 5095986. doi: 10.1093.
    PubMed    


  68. STONE GW, Genereux P, Harrington RA, White HD, et al
    Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
    Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
    PubMed     Abstract available


  69. MUKHERJEE D
    Coronary lesion complexity and the benefit of potent platelet inhibition after percutaneous coronary intervention.
    Eur Heart J. 2018 Sep 9. pii: 5093361. doi: 10.1093.
    PubMed    


  70. VON BARDELEBEN RS, Ruf T, Schulz E, Muenzel T, et al
    First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a surgical-like Clover technique.
    Eur Heart J. 2018 Sep 1. pii: 5089140. doi: 10.1093.
    PubMed    


    August 2018
  71. WINDECKER S, Neumann FJ, Juni P, Sousa-Uva M, et al
    Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of th
    Eur Heart J. 2018 Aug 25. pii: 5077827. doi: 10.1093.
    PubMed    


  72. PATEL NN, Murphy GJ
    Restrictive transfusion practice in cardiac surgery patients is safe, but what transfusion threshold is safe for my patient?
    Eur Heart J. 2018 Aug 21. pii: 5077325. doi: 10.1093.
    PubMed    


  73. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
    Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
    Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
    PubMed     Abstract available


  74. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
    Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  75. VARENNE O, Sinnaeve PR
    De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
    PubMed    


    June 2018
  76. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Eur Heart J. 2018;39:2192-2207.
    PubMed     Abstract available


  77. SIBBING D, Gross L, Trenk D, Jacobshagen C, et al
    Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.
    Eur Heart J. 2018 Jun 14. pii: 5037998. doi: 10.1093.
    PubMed     Abstract available


  78. KEREIAKES DJ
    Healing by design: in vivo insights following contemporary coronary stent deployment.
    Eur Heart J. 2018 Jun 13. pii: 5037243. doi: 10.1093.
    PubMed    


    May 2018
  79. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed    


  80. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
    Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
    Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
    PubMed     Abstract available


  81. CREMER PC, Zhang Y, Alu M, Rodriguez LL, et al
    The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA.
    Eur Heart J. 2018 May 8. pii: 4993744. doi: 10.1093.
    PubMed     Abstract available


  82. MEIER B, Kaltenbach M
    The world's first 2 coronary angioplasty patients.
    Eur Heart J. 2018;39:1588-1589.
    PubMed    


    April 2018
  83. PILGRIM T, Windecker S
    Expansion of transcatheter aortic valve implantation: new indications and socio-economic considerations.
    Eur Heart J. 2018 Apr 26. pii: 4986946. doi: 10.1093.
    PubMed    


  84. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Abstract available


  85. GOLWALA HB, Cannon CP, Steg PG, Doros G, et al
    Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2018 Apr 13. pii: 4970508. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  86. HULME W, Sperrin M, Curzen N, Kinnaird T, et al
    Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.
    Eur Heart J. 2018 Mar 22. pii: 4951577. doi: 10.1093.
    PubMed     Abstract available


  87. CAPODANNO D, Buccheri S
    Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics.
    Eur Heart J. 2018 Mar 22. pii: 4951529. doi: 10.1093.
    PubMed    


  88. NICHOLLS M
    Andre Simon, cardiac & transplant surgeon.
    Eur Heart J. 2018;39:974-975.
    PubMed    


  89. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Abstract available


  90. RUSINARU D, Bohbot Y, Ringle A, Marechaux S, et al
    Impact of low stroke volume on mortality in patients with severe aortic stenosis and preserved left ventricular ejection fraction.
    Eur Heart J. 2018 Mar 13. pii: 4934158. doi: 10.1093.
    PubMed     Abstract available


  91. RAHHAB Z, Ren B, de Jaegere PPT, Van Mieghem NMDA, et al
    Kissing balloon technique to secure the neo-left ventricular outflow tract in transcatheter mitral valve implantation.
    Eur Heart J. 2018 Mar 6. pii: 4922636. doi: 10.1093.
    PubMed    


  92. AFZAL S, Kleinebrecht L, Hellhammer K, Veulemans V, et al
    First-in-man: successful interventional closure of severe paravalvular leakage after surgical rapid deployment aortic valve replacement.
    Eur Heart J. 2018 Mar 5. pii: 4920929. doi: 10.1093.
    PubMed    


    February 2018
  93. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Abstract available


  94. VAN ROSENDAEL PJ, Delgado V, Bax JJ
    Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review.
    Eur Heart J. 2018 Feb 6. pii: 4840597. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  95. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Abstract available


  96. SANGEN H, Imori Y, Tara S, Yamamoto T, et al
    Haemodynamic deterioration due to intra-aortic balloon counterpulsation in takotsubo cardiomyopathy.
    Eur Heart J. 2018 Jan 16. pii: 4812642. doi: 10.1093.
    PubMed    


  97. SMITH CR
    Emergency cardiac surgery following TAVI: implications for the future.
    Eur Heart J. 2018 Jan 8. pii: 4792978. doi: 10.1093.
    PubMed    


  98. KRISTENSEN SD, Maeng M, Capodanno D, Wijns W, et al
    The year in cardiology 2017: coronary interventions.
    Eur Heart J. 2018 Jan 2. pii: 4781700. doi: 10.1093.
    PubMed    


  99. IUNG B, Delgado V, Lazure P, Murray S, et al
    Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study.
    Eur Heart J. 2018 Jan 2. pii: 4782671. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  100. EGGEBRECHT H, Vaquerizo B, Moris C, Bossone E, et al
    Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).
    Eur Heart J. 2017 Dec 14. pii: 4745749. doi: 10.1093.
    PubMed     Abstract available


  101. GAEDE L, Blumenstein J, Liebetrau C, Dorr O, et al
    Outcome after transvascular transcatheter aortic valve implantation in 2016.
    Eur Heart J. 2017 Dec 8. pii: 4710062. doi: 10.1093.
    PubMed     Abstract available


  102. LUSCHER TF
    Managing aortic stenosis with TAVI or surgery: risk assessement and long-term outcome.
    Eur Heart J. 2017;38:3327-3329.
    PubMed    


    November 2017
  103. ALKHOULI M, Carpenter E, Tarabishy A, Sengupta P, et al
    Annular rupture during transcatheter aortic valve replacement: novel treatment with amplatzer vascular plugs.
    Eur Heart J. 2017 Nov 13. doi: 10.1093.
    PubMed    


  104. LUSCHER TF
    Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
    Eur Heart J. 2017;38:3109-3113.
    PubMed    


  105. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Abstract available


    October 2017
  106. FENG Y, Zhao ZG, Baccaro J, Zeng MF, et al
    First-in-man implantation of a pre-packaged self-expandable dry-tissue transcatheter aortic valve.
    Eur Heart J. 2017 Oct 31. doi: 10.1093.
    PubMed    


  107. VAHANIAN A, Iung B
    Predicting the outcome of degenerative mitral regurgitation: a step forward but still a long way to go!
    Eur Heart J. 2017 Oct 25. doi: 10.1093.
    PubMed    


  108. CASTANO A, Narotsky DL, Hamid N, Khalique OK, et al
    Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Eur Heart J. 2017;38:2879-2887.
    PubMed     Abstract available


  109. GARGIULO P, Perrone-Filardi P
    Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosis.
    Eur Heart J. 2017;38:2888-2889.
    PubMed    


    September 2017
  110. LUSCHER TF
    From Cinderella to centre stage: valvular heart disease on the move.
    Eur Heart J. 2017;38:2693-2695.
    PubMed    


  111. LEU HB, Chang HH, Lin SM, Chen YH, et al
    Double trouble for transcatheter aortic valve implantation: a patient with no vascular access and high-risk features for bilateral coronary obstruction.
    Eur Heart J. 2017;38:2787.
    PubMed    


  112. IUNG B, Vahanian A
    Coronary obstruction: a rare but devastating complication during transcatheter aortic valve-in-valve implantation.
    Eur Heart J. 2017 Sep 6. doi: 10.1093.
    PubMed    


    August 2017
  113. BYRNE RA, Stefanini GG, Capodanno D, Onuma Y, et al
    Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed     Abstract available


  114. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Abstract available


  115. BAUMGARTNER H, Falk V, Bax JJ, De Bonis M, et al
    2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed    


  116. TARANTINI G, Nai Fovino L, Gersh BJ
    Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?
    Eur Heart J. 2017 Aug 24. doi: 10.1093.
    PubMed     Abstract available


  117. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
    Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Abstract available


  118. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Abstract available


  119. SCHULZ E, Beiras-Fernandez A, Rohsbach U, von Bardeleben RS, et al
    Successful transcatheter aortic valve-in-valve implantation in a patient having a chronic type A aortic dissection.
    Eur Heart J. 2017 Aug 10. doi: 10.1093.
    PubMed    


  120. TAMBURINO C, Barbanti M
    Transcatheter aortic valve implantation with a mechanical-expandable device: when perfection is hung on a 'wire'.
    Eur Heart J. 2017 Aug 1. doi: 10.1093.
    PubMed    


    July 2017
  121. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Abstract available


  122. ALFONSO F, Prati F
    Optical coherence tomography or intravascular ultrasound to optimize coronary stent implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed    


  123. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available


  124. TREIBEL TA, Lopez B, Gonzalez A, Menacho K, et al
    Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients.
    Eur Heart J. 2017 Jul 22. doi: 10.1093.
    PubMed     Abstract available


  125. SONDERGAARD L, De Backer O, Kofoed KF, Jilaihawi H, et al
    Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves.
    Eur Heart J. 2017;38:2201-2207.
    PubMed     Abstract available


  126. GENEREUX P, Pibarot P, Redfors B, Mack MJ, et al
    Staging classification of aortic stenosis based on the extent of cardiac damage.
    Eur Heart J. 2017 Jul 21. doi: 10.1093.
    PubMed     Abstract available


  127. CHAMBERS JB, Prendergast B, Iung B, Rosenhek R, et al
    Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.
    Eur Heart J. 2017;38:2177-2183.
    PubMed    


  128. WHITLOCK RP, McClure GR, Eikelboom JW
    Aortic valve replacement in younger patients.
    Eur Heart J. 2017 Jul 14. doi: 10.1093.
    PubMed    


    June 2017
  129. FALK V, Wohrle J, Hildick-Smith D, Bleiziffer S, et al
    Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.
    Eur Heart J. 2017 Jun 22. doi: 10.1093.
    PubMed     Abstract available


  130. GERCKENS U, Tamburino C, Bleiziffer S, Bosmans J, et al
    Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Abstract available


  131. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.
    Eur Heart J. 2017 Jun 12. doi: 10.1093.
    PubMed     Abstract available


  132. SCHULZ E, Tamm A, Kasper-Konig W, Beiras-Fernandez A, et al
    Transapical implantation of a transcatheter aortic valve prosthesis into a mitral annuloplasty ring guided by real-time three-dimensional cardiac computed tomography-fluoroscopy fusion imaging.
    Eur Heart J. 2017 Jun 12. doi: 10.1093.
    PubMed    


    May 2017
  133. SUKUL D, Bach DS
    Readmissions after transcatheter aortic valve implantation. What are they doing right? How can we do better?
    Eur Heart J. 2017 May 19. doi: 10.1093.
    PubMed    


  134. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Abstract available


  135. KORTELAND NM, Etnel JRG, Arabkhani B, Mokhles MM, et al
    Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation.
    Eur Heart J. 2017 May 10. doi: 10.1093.
    PubMed     Abstract available


    April 2017
  136. FRANGIEH AH, Kasel AM
    TAVI in Bicuspid Aortic Valves 'Made Easy'.
    Eur Heart J. 2017;38:1177-1181.
    PubMed    


  137. HEAD SJ, Celik M, Kappetein AP
    Mechanical versus bioprosthetic aortic valve replacement.
    Eur Heart J. 2017 Apr 20. doi: 10.1093.
    PubMed     Abstract available


  138. FRANZONE A, Pilgrim T, Arnold N, Heg D, et al
    Rates and predictors of hospital readmission after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  139. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  140. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Abstract available


    March 2017
  141. VOLLEMA EM, Kong WK, Katsanos S, Kamperidis V, et al
    Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  142. RUILE P, Neumann FJ
    Hypo-attenuated leaflet thickening of transcatheter aortic valves: jeopardy or epiphenomenon?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed    


  143. VAN ROSENDAEL PJ, Kamperidis V, Kong WK, van Rosendael AR, et al
    Computed tomography for planning transcatheter tricuspid valve therapy.
    Eur Heart J. 2017;38:665-674.
    PubMed     Abstract available


  144. TARAMASSO M, Pozzoli A, Guidotti A, Nietlispach F, et al
    Percutaneous tricuspid valve therapies: the new frontier.
    Eur Heart J. 2017;38:639-647.
    PubMed     Abstract available


  145. STEPHAN VON BARDELEBEN R, Tamm A, Emrich T, Munzel T, et al
    Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband.
    Eur Heart J. 2017;38:690.
    PubMed    


    February 2017
  146. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Abstract available


  147. SINNING JM
    Trying to square the circle? Integration of computed tomography data for the evaluation of mitral regurgitation.
    Eur Heart J. 2017 Feb 3. doi: 10.1093.
    PubMed    


    January 2017
  148. VAN ROSENDAEL PJ, van Wijngaarden SE, Kamperidis V, Kong WK, et al
    Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in patients undergoing transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jan 10. pii: ehw612. doi: 10.1093.
    PubMed     Abstract available


  149. KUWATA S, Taramasso M, Nietlispach F, Maisano F, et al
    Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation.
    Eur Heart J. 2017 Jan 10. pii: ehw660. doi: 10.1093.
    PubMed    


  150. DEBONNAIRE P, van der Kley F, Ajmone Marsan N, Delgado V, et al
    MitraClip improves mitral valve geometry in complex organic mitral regurgitation: insights from three-dimensional-echocardiography.
    Eur Heart J. 2017 Jan 10. pii: ehw645. doi: 10.1093.
    PubMed    


  151. ALFIERI O, Vahanian A
    The year in cardiology 2016: valvular heart disease.
    Eur Heart J. 2017 Jan 2. pii: ehw636. doi: 10.1093.
    PubMed    


    December 2016
  152. ABRAMOWITZ Y, Kazuno Y, Chakravarty T, Kawamori H, et al
    Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement.
    Eur Heart J. 2016 Dec 30. pii: ehw594. doi: 10.1093.
    PubMed     Abstract available


  153. LUSCHER TF
    Aortic stenosis: expanding treatment options.
    Eur Heart J. 2016;37:3483-3485.
    PubMed    


    November 2016
  154. KUWATA S, Taramasso M, Maisano F, Weber A, et al
    Infective endocarditis after transcatheter aortic valve implantation with LOTUS valve.
    Eur Heart J. 2016.
    PubMed    


    October 2016
  155. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Abstract available


  156. LESEVIC H, Frangieh AH, Kasel AM, Ott I, et al
    Successful percutaneous edge-to-edge repair in degenerative tricuspid valve regurgitation using the MitraClip system.
    Eur Heart J. 2016.
    PubMed    


    September 2016
  157. MOAT N, Brecker S
    Transfemoral TAVI is superior to SAVR in elderly high-risk patients with symptomatic severe aortic stenosis!
    Eur Heart J. 2016.
    PubMed    


  158. LUSCHER TF
    Aortic valve disease 2016: evaluation for and outcome of TAVI and surgery.
    Eur Heart J. 2016;37:2615-7.
    PubMed    


  159. LUSCHER TF
    From heart failure to transplantation: genes, miRNAs, and biomarkers.
    Eur Heart J. 2016;37:2561-3.
    PubMed    


    August 2016
  160. LUSCHER TF
    Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Eur Heart J. 2016;37:2443-5.
    PubMed    


    July 2016
  161. SIONTIS GC, Praz F, Pilgrim T, Mavridis D, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials.
    Eur Heart J. 2016.
    PubMed     Abstract available


    June 2016
  162. VAHANIAN A, Nataf P
    Let us preserve the harmonious development of transcatheter aortic valve implantation!
    Eur Heart J. 2016.
    PubMed    


    May 2016
  163. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    PubMed    


  164. FIGULLA HR, Webb JG, Lauten A, Feldman T, et al
    The transcatheter valve technology pipeline for treatment of adult valvular heart disease.
    Eur Heart J. 2016.
    PubMed     Abstract available


    April 2016
  165. ABDELGHANI M, Soliman OI, Schultz C, Vahanian A, et al
    Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal.
    Eur Heart J. 2016.
    PubMed     Abstract available


    March 2016
  166. CLAVEL MA, Magne J, Pibarot P
    Low-gradient aortic stenosis.
    Eur Heart J. 2016.
    PubMed     Abstract available


  167. KODALI S, Thourani VH, White J, Malaisrie SC, et al
    Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
    Eur Heart J. 2016.
    PubMed     Abstract available


  168. EGBE AC, Poterucha JT, Warnes CA
    Mixed aortic valve disease: midterm outcome and predictors of adverse events.
    Eur Heart J. 2016.
    PubMed     Abstract available


    February 2016
  169. SCHUELER R, Werner N, Nickenig G, Hammerstingl C, et al
    Catheter-based complete "Alfieri-Stich" via interventional annuloplasty and edge-to-edge repair for degenerative mitral regurgitation.
    Eur Heart J. 2016.
    PubMed    


    January 2016
  170. PURI R, Iung B, Cohen DJ, Rodes-Cabau J, et al
    TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation.
    Eur Heart J. 2016.
    PubMed     Abstract available


  171. ZUK K, Stortecky S, Wenaweser P, Huber C, et al
    Mechanical aortic valves and massive mitral calcifications should not preclude transcatheter mitral Valve-In-Ring TAVI device implantation.
    Eur Heart J. 2016.
    PubMed    


  172. SAMAD Z, Vora AN, Dunning A, Schulte PJ, et al
    Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction.
    Eur Heart J. 2016.
    PubMed     Abstract available


  173. BUDTS W, Roos-Hesselink J, Radle-Hurst T, Eicken A, et al
    Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.
    Eur Heart J. 2016.
    PubMed    


  174. CRESPO-LEIRO MG, Stypmann J, Schulz U, Zuckermann A, et al
    Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.
    Eur Heart J. 2016.
    PubMed     Abstract available


    November 2015
  175. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.
    Eur Heart J. 2015.
    PubMed     Abstract available


    September 2015
  176. ARSALAN M, Walther T, Smith RL 2nd, Grayburn PA, et al
    Tricuspid regurgitation diagnosis and treatment.
    Eur Heart J. 2015.
    PubMed     Abstract available


    June 2015
  177. ARZT S, Wilbring M, Knaut M
    Turned, wedged, but still no feeling: asymptomatic late transcatheter aortic valve dislocation into the LVOT.
    Eur Heart J. 2015.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: